ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,701 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaarPharmact Holding AG
Pharmact Holding AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Pharmact AG is the development and application of innovative medical solutions, particularly in the areas of atherosclerosis, diabetes mellitus, and severe liver diseases. The company develops genetically optimized enzymes and point-of-care tests (POCT) for the diagnosis and treatment of diseases, such as familial hypercholesterolemia. The core activity also includes research and development of new therapies and prevention products, as well as the commercial marketing of these products.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Pharmact Holding AG

✓ Offered5
Intellectual Property and Licensing Management
IP, brand and licensing management for patented biotechnological developments, including protection right establishment, worldwide exploitation and cooperation models via licences and partnerships.
Enzyme Innovation D016
Patented recombinant hyaluronidase with combined PH20 and HYAL4 activity, available for research, medical and industrial applications, as well as for OEM/API partners.
BELACT Active Substance Development
Innovative enzyme medicine for the treatment of familial hypercholesterolemia, with an initiated approval process, an industrially scalable manufacturing process and a therapeutic use concept.
Licensing and Delivery of D016
D016 is offered for licensing and delivery, available worldwide for research, medical and industrial applications and in various quality grades.
Safety Data Sheets and CoA for D016
Safety data sheets and certificates (CoA) for D016 quality grades in Research Use Only, Cosmetic/Pre-GMP and GMP-grade on request for professional users.
Trust & reputation

ranQ Trust Score of Pharmact Holding AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Pharmact Holding AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Pharmact Holding AG scores 85.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Pharmact Holding AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Pharmact Holding AG scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Pharmact Holding AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Pharmact Holding AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Pharmact Holding AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Pharmact Holding AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Pharmact Holding AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Zugerstrasse 76B
6340 Baar
Opening hours
Mon
08:00 - 17:00
Tue
08:00 - 17:00
Wed
08:00 - 17:00
Thu
08:00 - 17:00
Fri
08:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-101.500.286
Founded
1988 · 38 years
Last commercial register change
January 5, 2023
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    VA
    Vesifact AG
    Baar
    TP
    TAP Pharmaceuticals AG
    Baar
    SA
    Scalepharm AG
    Baar
    BS
    Biogen Switzerland AG
    Baar
    AP
    Aalto Pharma AG
    Baar
    PP
    Primex Pharmaceuticals AG
    Zug
    AP
    Atnahs Pharma Switzerland AG
    Zug
    AT
    Aurealis Therapeutics AG
    Zug